Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)
0.0780
-0.0280 (-26.42%)
Jul 14, 2026, 4:08 PM HKT
HKG:8217 Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 9.28 | 2.11 | 4.01 | 8.15 | 8.2 |
Trading Asset Securities | 51.38 | 28.06 | 22.71 | 36.06 | 36.5 |
Cash & Short-Term Investments | 60.65 | 30.17 | 26.72 | 44.22 | 44.7 |
Cash Growth | 101.02% | 12.94% | -39.58% | -1.08% | -6.30% |
Accounts Receivable | 22.34 | 39.62 | 48.08 | 54.76 | 89.75 |
Other Receivables | 4.53 | 0.97 | 1.49 | 1.52 | 1.99 |
Receivables | 26.87 | 40.59 | 49.56 | 56.28 | 91.74 |
Other Current Assets | 5.09 | 9.44 | 5.03 | 4.7 | 6.55 |
Total Current Assets | 92.61 | 80.2 | 81.31 | 105.19 | 143 |
Property, Plant & Equipment | - | 0.16 | 0.24 | 0.32 | 0.68 |
Other Long-Term Assets | - | - | - | - | 0.67 |
Total Assets | 92.61 | 80.37 | 81.55 | 105.51 | 144.35 |
Accounts Payable | 9.17 | 11.72 | 12.67 | 10.01 | 8.61 |
Accrued Expenses | 6.2 | 6.07 | 6.48 | 5.76 | 3.76 |
Short-Term Debt | - | 2.26 | 2.26 | 10.03 | 42.96 |
Current Portion of Long-Term Debt | 12 | 12 | 12 | 12 | 12 |
Current Portion of Leases | - | - | - | - | 0.16 |
Current Income Taxes Payable | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 |
Current Unearned Revenue | 0.27 | 1.52 | 1.52 | 1.52 | 3.4 |
Other Current Liabilities | 13.8 | 18.96 | 12.88 | 15.01 | 12.32 |
Total Current Liabilities | 42.08 | 53.15 | 48.44 | 54.96 | 83.83 |
Total Liabilities | 42.08 | 53.15 | 48.44 | 54.96 | 83.83 |
Common Stock | 48.3 | 48.3 | 48.3 | 48.3 | 48.3 |
Additional Paid-In Capital | - | 60.7 | 60.7 | 60.7 | 60.7 |
Retained Earnings | - | -98.56 | -96.13 | -78.69 | -69.16 |
Comprehensive Income & Other | 2.24 | 16.79 | 20.25 | 20.25 | 20.68 |
Shareholders' Equity | 50.54 | 27.22 | 33.12 | 50.55 | 60.51 |
Total Liabilities & Equity | 92.61 | 80.37 | 81.55 | 105.51 | 144.35 |
Total Debt | 12 | 14.26 | 14.26 | 22.03 | 55.12 |
Net Cash (Debt) | 48.65 | 15.91 | 12.45 | 22.18 | -10.42 |
Net Cash Growth | 205.84% | 27.77% | -43.87% | - | - |
Net Cash Per Share | 0.16 | 0.05 | 0.04 | 0.07 | -0.05 |
Filing Date Shares Outstanding | 301.86 | 301.86 | 301.86 | 301.86 | 301.86 |
Total Common Shares Outstanding | 301.86 | 301.86 | 301.86 | 301.86 | 301.86 |
Working Capital | 50.54 | 27.06 | 32.87 | 50.23 | 59.16 |
Book Value Per Share | 0.17 | 0.09 | 0.11 | 0.17 | 0.20 |
Tangible Book Value | 50.54 | 27.22 | 33.12 | 50.55 | 60.51 |
Tangible Book Value Per Share | 0.17 | 0.09 | 0.11 | 0.17 | 0.20 |
Land | - | 1.61 | 1.61 | 1.61 | 1.61 |
Machinery | - | - | - | 8.29 | 18.99 |
Order Backlog | 394.23 | 346.89 | 333.84 | 287.29 | 478.92 |